HMGB1 and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease, HMGB1 interacts with beta-amyloid (Aβ), promoting the formation of Aβ plaques and triggering axonal degradation through the TLR4-MARCKS signaling pathway, which is one of the hallmarks of early neurodegeneration.